Investor News Archives - Inify Laboratories

Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics

Investor News 2026-06-08

South Oxfordshire, UK, 8th June 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, today announced that it has entered into an agreement with University Hospitals […]

Inify Laboratories AB (publ) – Bulletin from the Annual General Meeting 2026

Annual General Meeting, Investor News 2026-05-21

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2026. The AGM resolved, with the required majority, on all matters in accordance with […]

Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden

Financial reports, Investor News 2026-04-29

STOCKHOLM – April 29, 2026 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, today announces significant progress in its UK market entry and continued sales […]

Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics

Investor News 2026-04-24

STOCKHOLM – April 24, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics in pathology, has entered into an agreement with the Swedish Region Jämtland Härjedalen. The agreement […]

Inify Laboratories – notice of Annual General Meeting on May 20, 2026

Annual General Meeting, Investor News 2026-04-15

Stockholm – April 15, 2026 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and diagnostics, hereby invites its shareholders to Annual General Meeting on May 20, […]

Inify Laboratories – Annual Report 2025

Annual reports, Financial reports, Investor News 2026-04-15

Stockholm – April 15, 2026 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2025. […]

Inify Laboratories – New share capital registered

Investor News 2026-03-24

Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company“) on 4 December 2025 regarding the resolution to issue 26,266,866 new shares in a private […]

Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Financial reports, Investor News 2026-02-25

STOCKHOLM – February 25, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, reports continued sales growth in the fourth quarter of 2025. Significant progress has […]

Correction: Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2026-01-30

Stockholm, Sweden, 30 January 2026, Reference is made to the stock exchange announcement made by Inify Laboratories AB (publ.) (the “Company“) on 27 January 2026 regarding allocation of new shares […]

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2026-01-27

Stockholm, Sweden, 27 January 2026; Inify Laboratories AB (publ.) (the “Company“) announces that the below primary insiders were allocated new shares at the subscription price in the repair issue announced […]

Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics

Inify Laboratories AB (publ) – Bulletin from the Annual General Meeting 2026

Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden

Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics

Inify Laboratories – notice of Annual General Meeting on May 20, 2026

Inify Laboratories – Annual Report 2025

Inify Laboratories – New share capital registered

Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Correction: Inify Laboratories – mandatory notification of trade

Inify Laboratories – mandatory notification of trade

Our services

Inify Laboratories

For Investors

Contact us

Social media